Form 4 for CLX Clorox
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0001225208-24-010085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-20 | 2024-11-18 | CLX | Rendle Linda J | CEO, Dir | M - OptEx | $117.81 | +26.9K | 156.9K | +21% | +$3.17M |
| D | 2024-11-20 | 2024-11-18 | CLX | Rendle Linda J | CEO, Dir | F - Tax | $169.10 | -22.8K | 134.1K | -15% | -$3.86M |
| DM | 2024-11-20 | 2024-11-18 | CLX | Rendle Linda J | CEO, Dir | M - OptEx | $0.00 | -26.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | M | A | 14,560 | $123.09 | 144,586 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-18 | M | A | 12,360 | $111.60 | 156,946 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-18 | F | D | 22,806 | $169.10 | 134,140 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-11-18 | M | D | 14,560 | $0.00 | 0 | D | $123.09 · 2017-09-13 to 2026-09-13 | 14,560 Common Stock | |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-11-18 | M | D | 12,360 | $0.00 | 0 | D | $111.60 · 2016-09-15 to 2025-09-15 | 12,360 Common Stock |